A role of herpes virus serology for the development of acute graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation
- PMID: 2190659
A role of herpes virus serology for the development of acute graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation
Abstract
Pretransplant herpes virus serology and acute graft-versus-host disease (GVHD) were studied in 379 leukaemic bone marrow transplant (BMT) recipients and their HLA-identical sibling donors. In logistic multivariate regression analysis pretransplant seropositivity to three or more different herpes viruses among the recipients was the only significant factor associated with grade II-IV acute GVHD (p = 0.03). If this factor was excluded, older donor age (p less than 0.001), absence of T cell depletion (p less than 0.001), pharmacological immunosuppression by monotherapy of methotrexate or cyclosporin versus a combination therapy of both (p = 0.002), and seropositivity to three or more herpes viruses among the donors (p = 0.03) prior to BMT, were also significantly associated with acute GVHD. The data indicate that latent herpes viruses in the host may act as minor histocompatibility antigens or by other means to trigger acute GVHD.
Similar articles
-
Correlation of pretransplant viral serology and complications of bone marrow transplantation.Ann Hematol. 1992 Jun;64 Suppl:A143-7. doi: 10.1007/BF01715369. Ann Hematol. 1992. PMID: 1322186 Review.
-
Pretransplant herpes virus serology and chronic graft-versus-host disease.Bone Marrow Transplant. 1989 Sep;4(5):547-52. Bone Marrow Transplant. 1989. PMID: 2551436
-
Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients.Bone Marrow Transplant. 1995 Dec;16(6):747-53. Bone Marrow Transplant. 1995. PMID: 8750264
-
Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.Bone Marrow Transplant. 1999 Mar;23(5):443-50. doi: 10.1038/sj.bmt.1701493. Bone Marrow Transplant. 1999. PMID: 10100557 Clinical Trial.
-
Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.Dan Med Bull. 2002 May;49(2):89-108. Dan Med Bull. 2002. PMID: 12064093 Review.
Cited by
-
Graft-versus-host disease following liver transplantation.J R Soc Med. 1992 Jun;85(6):313-4. J R Soc Med. 1992. PMID: 1625257 Free PMC article. No abstract available.
-
Correlation of pretransplant viral serology and complications of bone marrow transplantation.Ann Hematol. 1992 Jun;64 Suppl:A143-7. doi: 10.1007/BF01715369. Ann Hematol. 1992. PMID: 1322186 Review.
-
Intensification of GVHD prophylaxis interferes with the effects of pretransplant herpes virus serology on the occurrence of grades II-IV acute graft-versus-host disease.Ann Hematol. 1992 Jun;64 Suppl:A137-9. doi: 10.1007/BF01715367. Ann Hematol. 1992. PMID: 1322184 Clinical Trial.
-
General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home care.Support Care Cancer. 2015 May;23(5):1273-83. doi: 10.1007/s00520-014-2476-9. Epub 2014 Oct 17. Support Care Cancer. 2015. PMID: 25322970
-
Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care.Int J Hematol. 2021 May;113(5):712-722. doi: 10.1007/s12185-021-03087-w. Epub 2021 Feb 5. Int J Hematol. 2021. PMID: 33544322
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials